Fortrea Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Others were interested in
See all stocksFrequently asked questions
To buy Fortrea Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Fortrea Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Fortrea Holdings Inc. is FTRE:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Fortrea Holdings Inc. has its primary listing on NASDAQ. You can trade Fortrea Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Fortrea Holdings Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Fortrea Holdings Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Fortrea Holdings Inc..